|
Market Cap | 46.14M | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | 85.32% | Inst Own | - |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 1.14% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 448.31K | 52W Range | 3.66 - 11.78 |
|
|
|
Tungray Technologies, Inc. is a holding company, which engages in the provision of customized industrial manufacturing solutions to original equipment manufacturers in the semiconductors, printers, electronics, and home appliances sectors. The company was founded by Wanjun Yao on June 1, 2022 and is headquartered in Singapore. |
|
|
|
Market Cap | 2.64M | EPS (ttm) | -13.34 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -55.28% |
P/S | 0.92 | EPS next 5Y | - |
P/B | 0.10 | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | 0.02% | Inst Own | 2.76% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 2.36% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 520.00 |
Avg Volume | 553.81K | 52W Range | 1.10 - 23.66 |
|
|
|
SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and Brain Bright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. Its products include SCI-110, SCI-210, SCI-160, and CannAmide. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel. |
|
|
|
Market Cap | 6.78B | EPS (ttm) | -0.16 |
P/E | - | EPS this Y | -18.58% |
Forward P/E | 23.44 | EPS next Y | 14.98% |
PEG | - | EPS past 5Y | 20.57% |
P/S | 5.01 | EPS next 5Y | 46.20% |
P/B | 3.35 | EPS Q/Q | 11.89% |
Dividend | - | Sales Q/Q | 15.72% |
Insider Own | 23.73% | Inst Own | 54.14% |
Insider Trans | -0.71% | Inst Trans | 3.89% |
Short Float | 4.24% | Earnings | May 29/a |
Analyst Recom | 2.54 | Target Price | 19.54 |
Avg Volume | 7.54M | 52W Range | 14.12 - 27.87 |
|
|
Today | Downgrade |
BofA Securities |
Buy → Neutral |
$30 → $16 |
Today | Downgrade |
Truist |
Buy → Hold |
$32 → $14 |
Today | Downgrade |
William Blair |
Outperform → Mkt Perform |
|
Today | Downgrade |
TD Cowen |
Buy → Hold |
$28 → $17 |
Today | Downgrade |
KeyBanc Capital Markets |
Overweight → Sector Weight |
|
Today | Downgrade |
Needham |
Buy → Hold |
|
|
Today 10:11AM
|
Stocks to Watch Thursday: Salesforce, Kohl's, Tesla, Dell
(The Wall Street Journal) -35.25% |
09:59AM
|
PayPal upgraded, UiPath downgraded: Wall Street's top analyst calls
(The Fly) |
09:41AM
|
These Stocks Are Moving the Most Today: Salesforce, UiPath, Best Buy, Kohls, Foot Locker, HP Inc., C3.ai, Nutanix, and More
(Barrons.com) |
09:01AM
|
Why Is UiPath (PATH) Stock Down 30% Today?
(InvestorPlace) |
08:53AM
|
UiPath Stock Dives. The Cathie Wood Favorite Is Struggling to Match AI Hopes.
(Barrons.com) |
08:00AM
|
UiPath Named a Leader in Document Mining and Analytics Platforms by Independent Research Firm
(Business Wire) |
07:48AM
|
Salesforce Stock Slumps After Total Mess of Earnings. What Analysts Are Saying, and Other Tech News Today
(Barrons.com) |
07:47AM
|
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
(InvestorPlace) |
07:46AM
|
5 Things to Know Before the Stock Market Opens
(Investopedia) |
07:34AM
|
These Stocks Are Moving the Most Today
(Barrons.com) |
|
UiPath, Inc. engages in the development and provision of a software platform to automate business processes. It serves the public, healthcare, telecommunication, finance, and banking industries. The firm offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Gupta Ashim | Chief Financial Officer | May 06 '24 | Sale | 19.79 | 40,000 | 791,504 | 946,848 | May 08 07:48 PM | Gupta Ashim | Chief Financial Officer | May 06 '24 | Sale | 19.79 | 16,000 | 316,589 | 55,505 | May 08 07:48 PM | Gupta Ashim | Chief Financial Officer | Apr 04 '24 | Sale | 21.66 | 40,000 | 866,268 | 660,762 | Apr 09 05:49 PM | Gupta Ashim | Chief Financial Officer | Apr 04 '24 | Sale | 21.66 | 16,000 | 346,510 | 71,505 | Apr 09 05:49 PM | Gupta Ashim | Chief Financial Officer | Mar 15 '24 | Sale | 22.84 | 16,000 | 365,370 | 87,505 | Mar 19 09:18 PM |
|
|
| |
|
Market Cap | 7.96M | EPS (ttm) | -1.45 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -483.40% |
P/S | 0.28 | EPS next 5Y | - |
P/B | 0.40 | EPS Q/Q | -320.24% |
Dividend | - | Sales Q/Q | - |
Insider Own | 69.53% | Inst Own | 1.20% |
Insider Trans | 0.00% | Inst Trans | -98.39% |
Short Float | 68.46% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 10.71M | 52W Range | 1.50 - 113.00 |
|
|
|
MicroCloud Hologram, Inc. engages in research, development, and application of holographic technology. It operates through the Holographic Solutions and Holographic Technology Service segments. The company was founded in 2020 and is headquartered in New York, NY. |
|
|
|
Market Cap | 9.73M | EPS (ttm) | 0.63 |
P/E | 0.55 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | 0.12 | EPS past 5Y | 24.00% |
P/S | 0.03 | EPS next 5Y | 4.53% |
P/B | 0.06 | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | - | Inst Own | 0.89% |
Insider Trans | - | Inst Trans | 1.96% |
Short Float | - | Earnings | - |
Analyst Recom | 1.00 | Target Price | 12.01 |
Avg Volume | 35.41K | 52W Range | 0.36 - 7.50 |
|
|
|
Hywin Holdings Ltd. engages in the provision of financial services. Its services include wealth management, insurance brokerage, and asset management. The company was founded by Hongwei Han in July 19, 2019 and is headquartered in Shanghai, China. |
|
| |
|
Market Cap | 7.63M | EPS (ttm) | -4.36 |
P/E | - | EPS this Y | -90.56% |
Forward P/E | - | EPS next Y | -11.37% |
PEG | - | EPS past 5Y | 34.83% |
P/S | 0.24 | EPS next 5Y | 3.20% |
P/B | 1.06 | EPS Q/Q | -97.18% |
Dividend | - | Sales Q/Q | -69.73% |
Insider Own | 45.12% | Inst Own | 40.53% |
Insider Trans | 9.19% | Inst Trans | -24.53% |
Short Float | 3.66% | Earnings | May 15/a |
Analyst Recom | 1.00 | Target Price | 18.00 |
Avg Volume | 78.94K | 52W Range | 1.12 - 9.45 |
|
|
|
Molecular Templates, Inc. engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. It utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. The company was founded by Eric E. Poma, Jean Gariepy, and Leigh Revers in 2001 and is headquartered in Austin, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
BIOTECH TARGET N V | 10% Owner | Apr 02 '24 | Buy | 2.35 | 250,000 | 587,500 | 1,279,820 | Apr 04 08:13 PM | BIOTECH TARGET N V | 10% Owner | Jul 17 '23 | Buy | 0.47 | 4,255,319 | 2,000,000 | 15,447,322 | Jul 19 03:14 PM |
|
|
|
|
Market Cap | 89.08M | EPS (ttm) | -1.78 |
P/E | - | EPS this Y | 8.19% |
Forward P/E | - | EPS next Y | 14.73% |
PEG | - | EPS past 5Y | -73.43% |
P/S | - | EPS next 5Y | - |
P/B | 0.72 | EPS Q/Q | -5.52% |
Dividend | - | Sales Q/Q | - |
Insider Own | 13.44% | Inst Own | 75.63% |
Insider Trans | 0.00% | Inst Trans | 1.19% |
Short Float | 5.91% | Earnings | May 09/a |
Analyst Recom | 1.25 | Target Price | 14.06 |
Avg Volume | 299.01K | 52W Range | 1.37 - 5.70 |
|
|
|
Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Cambridge, MA. |
|
| |
|
Market Cap | 3.06M | EPS (ttm) | -42.75 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 62.30% |
P/S | 1.55 | EPS next 5Y | - |
P/B | - | EPS Q/Q | 94.28% |
Dividend | - | Sales Q/Q | -28.34% |
Insider Own | 8.70% | Inst Own | 12.86% |
Insider Trans | 251.62% | Inst Trans | - |
Short Float | 4.22% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 32.00 |
Avg Volume | 72.85K | 52W Range | 1.30 - 398.40 |
|
|
|
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The company was founded by Raj Mehra in 1987 and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Mehra Raj | See Remarks | Dec 01 '23 | Buy | 1.32 | 75,757 | 99,999 | 185,142 | Dec 01 04:16 PM | Golembiewski Michael Joseph | Chief Financial Officer | Nov 30 '23 | Buy | 1.21 | 83,000 | 100,222 | 86,450 | Dec 01 04:16 PM |
|
|
|
|
Market Cap | 12.98M | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 0.12 | EPS Q/Q | -225.44% |
Dividend | - | Sales Q/Q | - |
Insider Own | 77.57% | Inst Own | 0.14% |
Insider Trans | 0.00% | Inst Trans | -0.51% |
Short Float | 7.12% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 770.48K | 52W Range | 1.80 - 156.00 |
|
|
|
MicroAlgo, Inc. operates as a holding company, which engages in the development and application of bespoke central processing algorithms. Its services include algorithm optimization, accelerating computing power without the need for hardware upgrades, lightweight data processing, and data intelligence. The company was founded May 14, 2018 and is headquartered in New York, NY. |
|
|
|
Market Cap | 26.73M | EPS (ttm) | -2.20 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 18.24% |
P/S | 0.06 | EPS next 5Y | - |
P/B | 0.47 | EPS Q/Q | -495.69% |
Dividend | - | Sales Q/Q | 5.16% |
Insider Own | 27.41% | Inst Own | 45.78% |
Insider Trans | 0.00% | Inst Trans | 1.44% |
Short Float | 3.63% | Earnings | May 13/a |
Analyst Recom | 3.00 | Target Price | 5.00 |
Avg Volume | 39.23K | 52W Range | 1.34 - 4.00 |
|
|
|
Ampco-Pittsburgh Corp. is engaged in the manufacture and sale of custom designed engineering products. It operates through the Forged and Cast Engineered Products, and Air and Liquid Processing segments. The Forged and Cast Engineered Products segment produces forged hardened steel rolls, cast rolls and open-die forged products. Forged hardened steel rolls are used primarily in cold rolling mills by producers of steel, aluminum and other metals. The Air and Liquid Processing segment includes the Aerofin, Buffalo Air Handling, and Buffalo Pumps divisions. The company was founded in 1929 and is headquartered in Carnegie, PA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
McNair Darrell L | Director | Sep 13 '23 | Buy | 3.12 | 3,000 | 9,360 | 6,640 | Sep 20 12:46 PM | DiSanto Frederick D. | Director | Jun 29 '23 | Buy | 2.99 | 7,399 | 22,123 | 47,177 | Jul 03 11:41 AM | DiSanto Frederick D. | Director | Jun 28 '23 | Buy | 2.85 | 918 | 2,616 | 39,778 | Jul 03 11:41 AM | DiSanto Frederick D. | Director | Jun 23 '23 | Buy | 2.94 | 2,000 | 5,880 | 38,860 | Jun 26 11:35 AM | DiSanto Frederick D. | Director | Jun 22 '23 | Buy | 2.94 | 5,000 | 14,700 | 36,860 | Jun 26 11:35 AM |
|
|
|